Skip to main content
. 2024 Dec 11;18:5947–5960. doi: 10.2147/DDDT.S476173

Table 5.

Pharmacokinetic Parameters of Nemonoxacin Following Intravenous (1 mg/kg) Administration

n=5 Parameters Mean±S.D.
Plasma disposition T1/2,α (min) 12.8±7.2
T1/2,β (min) 238.6±29.5
CL (mL/min/kg) 24.6±5.8
Vss (mL/kg) 7101.8±1971.2
AUC0-480 (μg.min/mL) 29.9±6.6
Biliary excretion Ae0-480 (μg) 23.9±5.3
AUC0-480 (μg.min/mL) 1505.6±319.6
AUCbile/plasma 50.7±6.9

Abbreviations: T1/2,α, half-life of alpha phase; T1/2,β, half-life of beta phase; CL, clearance; Vss, volume of distribution; AUC0-480, area under curve of 0–480 min; Ae0-480, cumulative amount excreted in bile over the 480‐min collection interval.